Zhengqin Gu

Zhengqin Gu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2019 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
YSYuanzhen Suo
Yuanzhen Suo
ZGZhengqin Gu
Zhengqin Gu
XWXunbin Wei
Xunbin Wei

1 January 2021 in International Journal of Medical Sciences
Verified
Journal Article
Open access
BSBowen Shi
Bowen Shi
JDJie Ding
Jie Ding
JQJun Qi
Jun Qi
ZGZhengqin Gu
Zhengqin Gu
Background: Large-scale loss-of-function screening database such as Cancer Dependency Map (Depmap) provide abundant resources. Investigation of these potential dependency genes from human cancer cell lines in the real-world patients cohort would evaluate their prognostic value thus facilitate their clinical application and guide drug development.

11 August 2022 in International Immunopharmacology
Verified
Journal Article
Open access
SCShaojun Chen
Shaojun Chen
SQSubo Qian
Subo Qian
LZLin Zhang
Lin Zhang
XPXiuwu Pan
Xiuwu Pan
FQFajun Qu
Fajun Qu
HSHaibo Shen
Haibo Shen
Tumor-associated macrophages (TAMs) promote tumor cell growth and metastasis in various human cancers. However, the role of TAMs in renal cell carcinoma (RCC) is rarely investigated. Herein, we observed that the infiltration of TAMs was obviously elevated in RCC tumor tissues, high infiltration of TAMs was closely associated with tumor progression and poor prognosis in RCC patients. In vitro assays further indicated that the conditioned medium of TAMs (TAMs CM) facilitated migration, invasion, and epithelial-mesenchymal transition (EMT) in RCC cells. Moreover, we found that IL-6 was involved in the functions of TAMs in RCC; IL-6 neutralizing antibody (IL-6NA) partly abolished the effect of TAMs on RCC cells. In addition, we demonstrated that TAMs might exert their roles by activating STAT3 signaling in RCC, and IL-6 was responsible for TAMs-induced STAT3 signaling activation. In conclusion, our results revealed that high infiltration of TAMs may promote RCC cells migration, invasion, and EMT via modulating IL-6/STAT3 signaling, further suggesting a potential of novel treatment strategies targeting TAMs or IL-6 for metastatic RCC.

23 April 2018 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
KPKai Pang
Kai Pang
CXChengying Xie
Chengying Xie
ZYZhangru Yang
Zhangru Yang
YSYuanzhen Suo
Yuanzhen Suo
XZXi Zhu
Xi Zhu
ZGZhengqin Gu
Zhengqin Gu

15 February 2024 in Cancer Letters
Verified
Journal Article
Closed access
HCHaojie Chen
Haojie Chen
KDKeqin Dong
Keqin Dong
JDJie Ding
Jie Ding
JXJia Xia
Jia Xia
FQFajun Qu
Fajun Qu
YYYu Yongjiang
Yu Yongjiang

12 April 2021 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
JWJing Wen
Jing Wen
TTTianchen Tang
Tianchen Tang
SKSaima Kanwal
Saima Kanwal
YLYongzheng Lu
Yongzheng Lu
CTChunxian Tao
Chunxian Tao
ZGZhengqin Gu
Zhengqin Gu
Tumor cells circulating in the peripheral blood are the prime cause of cancer metastasis and death, thus the identification and discrimination of these rare cells are crucial in the diagnostic of cancer. As a label-free detection method without invasion, Raman spectroscopy has already been indicated as a promising method for cell identification. This study uses a confocal Raman spectrometer with 532 nm laser excitation to obtain the Raman spectrum of living cells from the kidney, liver, lung, skin, and breast. Multivariate statistical methods are applied to classify the Raman spectra of these cells. The results validate that these cells can be distinguished from each other. Among the models built to predict unknown cell types, the quadratic discriminant analysis model had the highest accuracy. The demonstrated analysis model, based on the Raman spectrum of cells, is propitious and has great potential in the field of biomedical for classifying circulating tumor cells in the future.